Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pseudomyxoma Peritonei × Mitomycin × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 16 Non-Muscle Invasive Bladder Neoplasms 12 Carcinoma, Transitional Cell 9 Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Anus Neoplasms 5 Lung Neoplasms 4 Carcinoma, Hepatocellular 3 Carcinoma 3 Stomach Neoplasms 2 Colonic Neoplasms 2 Anal Canal Carcinoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pseudomyxoma Peritonei 1 Pancreatic Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms, Squamous Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mesothelioma, Malignant 1 Hyperthermia 1 Head and Neck Neoplasms 1 Epstein-Barr Virus Infections 1 Disease 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Appendiceal Neoplasms 1

Interventions

cryoprecipitate coagulum 1 Mitomycin 1 Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06513065 2026-02-19

HIPEC-PMP

University of Southampton

Phase 3 Recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡